HeartSciences Inc.
HeartSciences Inc.
- Market cap
- $133.18K
Your view on HSCSW
Overview
What the company does, where it operates, and who runs it.
About HeartSciences Inc.
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Andrew Simpson
- Headquarters
- 550 Reserve Street, Southlake, TX, US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Andrew Simpson
- Headquarters
- 550 Reserve Street, Southlake, TX, US
Heart Test Laboratories, Inc. is a medical technology enterprise dedicated to the creation of diagnostic instruments for cardiovascular health. The company's primary offering is the MyoVista wavECG, a sophisticated 12-lead resting electrocardiograph.
This device provides essential diagnostic insights into cardiac dysfunction, in addition to supplying standard 12-lead resting ECG information. Serving a diverse range of medical environments, its products are adopted by clinics, physicians' offices, urgent care centers, and hospitals.
Founded in 2007, the firm's operations are headquartered in Southlake, Texas.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for HeartSciences Inc.. Starting points for HeartSciences Inc.: EPS -$2.80, beta 1.86 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for HeartSciences Inc.. Trailing twelve-month EPS for HeartSciences Inc. stands at -$2.80. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings per share estimates
| Per share | This quarterJul 2022 | Next quarterJan 2023 | This yearYear to Dec 2025 | Next yearYear to Dec 2026 |
|---|---|---|---|---|
| Average estimate | −$28.00 | −$16.00 | −$3.47 | −$2.46 |
| Lowest estimate | −$28.00 | −$16.00 | −$3.47 | −$2.46 |
| Highest estimate | −$28.00 | −$16.00 | −$3.47 | −$2.46 |
| Number of analysts | 1 | 1 | 1 | 1 |
| A year ago | — | — | −$9.34 | — |
| Growth vs a year ago | — | — | +62.8% | — |
Revenue estimates
| Total | This quarterJul 2022 | Next quarterJan 2023 | This yearYear to Dec 2025 | Next yearYear to Dec 2026 |
|---|---|---|---|---|
| Average estimate | $3000.00 | $1000.00 | $50000.00 | $17100.00 |
| Lowest estimate | $3000.00 | $1000.00 | $50000.00 | $17100.00 |
| Highest estimate | $3000.00 | $1000.00 | $50000.00 | $17100.00 |
| Number of analysts | 1 | 1 | 1 | 1 |
| A year ago | — | — | $4350.00 | — |
| Growth vs a year ago | — | — | +1049.4% | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for HeartSciences Inc.. HeartSciences Inc. has reported as a listed company since 2022. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | Mkt cap |
|---|---|---|---|---|---|
| BBLGBone Biologics Corporation | Healthcare | Biotechnology | $909,962 | ||
| BJDXBluejay Diagnostics, Inc. | Healthcare | Medical - Devices | $1.9M | ||
| DHAIDIH Holding US, Inc. | Healthcare | Medical - Devices | — | ||
| GCTKGlucoTrack, Inc. | Healthcare | Medical - Devices | $179,582 | ||
| MOVEMovano Inc. | Healthcare | Medical - Devices | $103.2M | ||
| NDRAENDRA Life Sciences Inc. | Healthcare | Medical - Diagnostics & Research | $5.4M | ||
| SHPHShuttle Pharmaceuticals Holdings, Inc. | Healthcare | Drug Manufacturers - Specialty & Generic | $16.6M | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| PXMBFPaxman AB (publ) | Healthcare | OTC | $149.9M | ||
| PYNKFPerimeter Medical Imaging AI, Inc. | Healthcare | OTC | $22.3M | ||
| QSIQuantum-Si incorporated | Healthcare | NASDAQ | $181.6M | ||
| QTIQT Imaging Holdings, Inc. | Healthcare | NASDAQ | $28.2M | ||
| QTRXQuanterix Corporation | Healthcare | NASDAQ | $93.1M | ||
| RBOTVicarious Surgical Inc. | Healthcare | NYSE | $17.7M | ||
| RCELAVITA Medical, Inc. | Healthcare | NASDAQ | $388.0M | ||
| RDGLVivos Inc. | Healthcare | OTC | $38.5M | ||
| RMSLREMSleep Holdings, Inc. | Healthcare | OTC | $9.5M | ||
| RPIDRapid Micro Biosystems, Inc. | Healthcare | NASDAQ | $33.6M | ||
| RTGNRetinalGenix Technologies Inc. | Healthcare | OTC | $59.5M | ||
| RXSTRxSight, Inc. | Healthcare | NASDAQ | $187.4M | ||
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold HeartSciences Inc., and how their positions are changing. At a $133,180 market value, institutional positions materially move HeartSciences Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by HeartSciences Inc. executives and directors. Shares of HeartSciences Inc. have traded between $0.04 and $0.07 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for HeartSciences Inc.. Coverage tracks HeartSciences Inc. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of HeartSciences Inc.